The Sunday Times reports mentioning unnamed sources that KKR & Co LP (NYSE:KKR) is thinking over a £1.8 billion or $2.9 billion takeover offer for Trader Media Group, the corporation behind leading United Kingdom used car website Autotrader.
The report mentions that Private equity group KKR is believed to be one of many takeover firms eyeing Trader Media, which is 50.1%-owned by the Guardian Media Group PLC, with Apax Partners controlling the rest.
It further adds that Bauer Media Group is also reported to be a suitor for the parent corporation of Autotrader.
Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Carlyle Group LP (NASDAQ:CG) fell -1.30% to settle at $25.85, Apollo Global Management LLC (NYSE:APO) moved down -0.29% to end at $17.23 while Fortress Investment Group LLC (NYSE:FIG) plunged -0.91% to finish at $4.34 on Friday.
KKR & Co. L.P. (NYSE:KKR) last session’s volume of 903,939 shares was lower than its average volume of 1.38 million shares. The stock after opening at $14.62 hit high price of $14.76 and then closed at $14.70 by scoring +0.41%.
KKR generated revenue of $600.18 million in the previous twelve months and earned $510.25 million.
The KKR’s past twelve months’ price to sales ratio was 5.97 and price to cash ratio remained 2.23. As far as the returns are concerned, KKR’s return on equity was recorded as 32.84% and return on investment increased 206.45% while its return on asset stayed at 17.39%.
The stock showed weekly upbeat performance of 0.89% which was maintained for the month at 5.83%. Likewise the positive performance for the quarter was recorded as 4.03% and for the year was 16.21% while the YTD performance remained at 21.49%.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL